Dabigatran	B:C2348066
:	O
A	O
new	O
oral	O
anticoagulant	I:C0354604
.	O

Dabigatran	O
:	O
A	O
new	O
oral	B:C0354604
anticoagulant	I:C0354604
.	O

Guidelines	B:C0162791
to	O
follow	O
in	O
oral	O
surgery	I:C0524861
procedures	I:C0524861
.	O

Guidelines	O
to	O
follow	O
in	O
oral	B:C0524861
surgery	I:C0524861
procedures	I:C0524861
.	O

A	O
systematic	O
review	B:C0282441
of	I:C0282441
the	I:C0282441
literature	I:C0282441
Dabigatran	O
is	O
a	O
newly	O
commercialized	O
drug	O
that	O
is	O
replacing	O
other	O
anticoagulants	O
in	O
the	O
prevention	O
of	O
venous	O
thromboembolism	I:C1861172
,	O
stroke	O
and	O
systemic	O
arterial	O
valve	O
embolism	O
.	O

A	O
systematic	O
review	O
of	I:C0282441
the	I:C0282441
literature	I:C0282441
Dabigatran	B:C2348066
is	O
a	O
newly	O
commercialized	O
drug	O
that	O
is	O
replacing	O
other	O
anticoagulants	O
in	O
the	O
prevention	O
of	O
venous	O
thromboembolism	I:C1861172
,	O
stroke	O
and	O
systemic	O
arterial	O
valve	O
embolism	O
.	O

A	O
systematic	O
review	O
of	I:C0282441
the	I:C0282441
literature	I:C0282441
Dabigatran	O
is	O
a	O
newly	O
commercialized	O
drug	B:C1254351
that	O
is	O
replacing	O
other	O
anticoagulants	O
in	O
the	O
prevention	O
of	O
venous	O
thromboembolism	I:C1861172
,	O
stroke	O
and	O
systemic	O
arterial	O
valve	O
embolism	O
.	O

A	O
systematic	O
review	O
of	I:C0282441
the	I:C0282441
literature	I:C0282441
Dabigatran	O
is	O
a	O
newly	O
commercialized	O
drug	O
that	O
is	O
replacing	O
other	O
anticoagulants	B:C0003280
in	O
the	O
prevention	O
of	O
venous	O
thromboembolism	I:C1861172
,	O
stroke	O
and	O
systemic	O
arterial	O
valve	O
embolism	O
.	O

A	O
systematic	O
review	O
of	I:C0282441
the	I:C0282441
literature	I:C0282441
Dabigatran	O
is	O
a	O
newly	O
commercialized	O
drug	O
that	O
is	O
replacing	O
other	O
anticoagulants	O
in	O
the	O
prevention	O
of	O
venous	B:C1861172
thromboembolism	I:C1861172
,	O
stroke	O
and	O
systemic	O
arterial	O
valve	O
embolism	O
.	O

A	O
systematic	O
review	O
of	I:C0282441
the	I:C0282441
literature	I:C0282441
Dabigatran	O
is	O
a	O
newly	O
commercialized	O
drug	O
that	O
is	O
replacing	O
other	O
anticoagulants	O
in	O
the	O
prevention	O
of	O
venous	O
thromboembolism	I:C1861172
,	O
stroke	B:C0038454
and	O
systemic	O
arterial	O
valve	O
embolism	O
.	O

It	O
acts	O
directly	O
on	O
thrombin	B:C0040018
presenting	O
in	O
a	O
dynamic	O
and	O
predictable	O
way	O
,	O
which	O
does	O
not	O
require	O
monitoring	O
these	O
patients	O
.	O

Therefore	O
,	O
we	O
consider	O
the	O
need	O
to	O
assess	O
whether	O
their	O
use	O
increases	O
the	O
risk	O
of	O
bleeding	O
involved	O
before	O
any	O
dental	B:C0011331
treatment	I:C0011331
.	O

We	O
performed	O
a	O
systematic	O
review	O
with	O
a	O
bibliographic	O
search	O
in	O
PubMed	B:C1138432
/	O
Medline	O
along	O
with	O
the	O
Cochrane	O
Library	I:C0023625
.	O

We	O
performed	O
a	O
systematic	O
review	O
with	O
a	O
bibliographic	O
search	O
in	O
PubMed	O
/	O
Medline	B:C0025141
along	O
with	O
the	O
Cochrane	O
Library	I:C0023625
.	O

We	O
performed	O
a	O
systematic	O
review	O
with	O
a	O
bibliographic	O
search	O
in	O
PubMed	O
/	O
Medline	O
along	O
with	O
the	O
Cochrane	B:C0023625
Library	I:C0023625
.	O

We	O
excluded	O
articles	O
dealing	O
with	O
all	O
anticoagulants	B:C0003280
other	O
than	O
dabigatran	O
,	O
and	O
works	O
about	O
surgical	O
treatments	I:C0543467
in	O
anatomical	O
locations	I:C0923870
other	O
than	O
the	O
oral	O
cavity	I:C0226896
.	O

We	O
excluded	O
articles	O
dealing	O
with	O
all	O
anticoagulants	O
other	O
than	O
dabigatran	B:C2348066
,	O
and	O
works	O
about	O
surgical	O
treatments	I:C0543467
in	O
anatomical	O
locations	I:C0923870
other	O
than	O
the	O
oral	O
cavity	I:C0226896
.	O

We	O
excluded	O
articles	O
dealing	O
with	O
all	O
anticoagulants	O
other	O
than	O
dabigatran	O
,	O
and	O
works	O
about	O
surgical	B:C0543467
treatments	I:C0543467
in	O
anatomical	O
locations	I:C0923870
other	O
than	O
the	O
oral	O
cavity	I:C0226896
.	O

We	O
excluded	O
articles	O
dealing	O
with	O
all	O
anticoagulants	O
other	O
than	O
dabigatran	O
,	O
and	O
works	O
about	O
surgical	O
treatments	I:C0543467
in	O
anatomical	B:C0923870
locations	I:C0923870
other	O
than	O
the	O
oral	O
cavity	I:C0226896
.	O

We	O
excluded	O
articles	O
dealing	O
with	O
all	O
anticoagulants	O
other	O
than	O
dabigatran	O
,	O
and	O
works	O
about	O
surgical	O
treatments	I:C0543467
in	O
anatomical	O
locations	I:C0923870
other	O
than	O
the	O
oral	B:C0226896
cavity	I:C0226896
.	O

We	O
included	O
a	O
total	O
of	O
13	O
papers	O
of	O
which	O
1	O
was	O
a	O
randomized	B:C0206034
clinical	I:C0206034
trial	I:C0206034
,	O
9	O
narrative	O
literature	O
reviews	O
,	O
1	O
case	O
series	I:C0150093
,	O
2	O
clinical	O
cases	O
and	O
1	O
expert	O
opinion	O
.	O

We	O
included	O
a	O
total	O
of	O
13	O
papers	O
of	O
which	O
1	O
was	O
a	O
randomized	O
clinical	I:C0206034
trial	I:C0206034
,	O
9	O
narrative	O
literature	O
reviews	O
,	O
1	O
case	B:C0150093
series	I:C0150093
,	O
2	O
clinical	O
cases	O
and	O
1	O
expert	O
opinion	O
.	O

Because	O
we	O
did	O
not	O
obtain	O
any	O
properly	O
designed	O
clinical	B:C0008976
trials	I:C0008976
,	O
we	O
were	O
unable	O
to	O
conduct	O
a	O
meta-	O
analysis	I:C0920317
.	O

Because	O
we	O
did	O
not	O
obtain	O
any	O
properly	O
designed	O
clinical	O
trials	I:C0008976
,	O
we	O
were	O
unable	O
to	O
conduct	O
a	O
meta-	B:C0920317
analysis	I:C0920317
.	O

Currently	O
,	O
there	O
is	O
no	O
consensus	O
on	O
the	O
procedure	B:C0543467
to	O
be	O
followed	O
in	O
patients	O
taking	O
dabigatran	O
.	O

Currently	O
,	O
there	O
is	O
no	O
consensus	O
on	O
the	O
procedure	O
to	O
be	O
followed	O
in	O
patients	O
taking	O
dabigatran	B:C2348066
.	O

However	O
,	O
all	O
authors	O
agree	O
to	O
treat	O
each	O
case	O
individually	O
in	O
accordance	O
to	O
the	O
risk	O
of	O
embolism	B:C0013922
,	O
postoperative	O
bleeding	I:C0032788
and	O
renal	O
function	I:C0232804
.	O

However	O
,	O
all	O
authors	O
agree	O
to	O
treat	O
each	O
case	O
individually	O
in	O
accordance	O
to	O
the	O
risk	O
of	O
embolism	O
,	O
postoperative	B:C0032788
bleeding	I:C0032788
and	O
renal	O
function	I:C0232804
.	O

However	O
,	O
all	O
authors	O
agree	O
to	O
treat	O
each	O
case	O
individually	O
in	O
accordance	O
to	O
the	O
risk	O
of	O
embolism	O
,	O
postoperative	O
bleeding	I:C0032788
and	O
renal	B:C0232804
function	I:C0232804
.	O

Also	O
,	O
it	O
is	O
necessary	O
to	O
perform	O
minimally	O
invasive	B:C4048276
interventions	I:C4048276
,	O
and	O
take	O
the	O
appropriate	O
local	O
anti-hemolytic	O
measures	I:C0199176
.	O

Also	O
,	O
it	O
is	O
necessary	O
to	O
perform	O
minimally	O
invasive	O
interventions	I:C4048276
,	O
and	O
take	O
the	O
appropriate	O
local	O
anti-hemolytic	B:C0199176
measures	I:C0199176
.	O

